Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Too much epidermal growth factor can cause hair loss.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Alopecia areata treatment varies, with no optimal method established yet.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Testosterone's effects on COVID-19 are unclear and need more research.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Yellow dots are common in severe alopecia areata.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Lower irisin levels in the blood may indicate more severe acne.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Male gender and family history predict alopecia areata recurrence.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

New understanding and treatments for hair loss are improving, but more research is needed.

Sweat glands and hair follicles are determined by opposing signals, with BMPs promoting sweat glands and blocking BMPs leading to hair follicles.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.